A. Saethre-Chotzen syndrome e Incorrect. This TWIST1-related craniosynostosis may be associated with hypertelorism and syndactyly; however, it typically presents with characteristic ears (small pinna with large crus), ptosis, and facial asymmetry. 
D.
Crouzon syndrome e Incorrect. This FGFR2-related craniosynostosis also presents with eye and cranial malformations; however, these include significant proptosis, a protruding mandible, and external strabismus, without extracranial manifestations involving the hands and feet.
1 Acanthosis nigricans is a dermatologic association with Crouzon syndrome. 1, 2 E. Pfeiffer syndrome e Incorrect. Pfeiffer syndrome can similarly present with mid-facial deformities and hearing loss, but the broad, radially deviated thumbs or big toes characteristic of this syndrome are not described.
1,2 Cutaneous hypopigmentation can also be associated with Pfeiffer syndrome. A. Kaposi sarcoma e Incorrect. Kaposi sarcomas are vascular tumors like PGs, but histopathologically, the absence of atypical spindle cells and bizarre vascular channels helps to differentiate a benign PG from Kaposi sarcoma. 3 B. ANM e Incorrect. Although they may both present as vascular nodules, ANMs tend to have a dull red hue, bleed less, and be slower growing, whereas most PGs are bright red and friable. On histology, melanin pigment is usually decreased or absent in ANM.
C. Bacillary angiomatosis e Incorrect. PG may clinically be mistaken for bacillary angiomatosis, an infection with Bartonella spp primarily seen in HIVinfected individuals, but PG would be distinguished by an absence of granular bacterial material histologically. 3 D. PG e Correct. PG classically presents as a rapidly growing vascular tumor that can arise from stimuli such as local irritation, acute or chronic trauma, or humoral factors. The acne treatment isotretinoin is also a known cause of PGs. 4 Histologically, the lesion consists of distinctive lobular clusters of capillaries in a dense stroma, accompanied by an inflammatory infiltrate. A. Topical retinoid e Incorrect. Oral isotretinoin, not topical, is found to be most effective at resolving acneiform lesions associated with Apert syndrome. 5 
B.
Oral antibiotic e Incorrect. Although tetracyclines inhibit the FGFR2b downstream expression and activity of metalloproteinases, this inhibition has not been sufficient in treating this gain-offunction FGF2 mutation. 5 C. Isotretinoin e Correct. The onset of acne in Apert syndrome, and often oily skin, occurs in early puberty. When androgen levels increase, they promote FGF synthesis, activate the gain-of-function FGF2 mutation, and cause the severe acneiform lesions in these patients. FGF2b signaling is known to play a crucial role in the pathogenesis of acne. Although most drugs target single regions of the FGF2b signaling cascade, oral retinoids disrupt multiple regulatory steps and signals in the FGFR2 pathway and therefore provide the most effective treatment for patients with the gain-of-function FGF2 mutation. 2, 5 However, depending on the acne severity, isotretinoin may not be required in all patients. A risk-benefit assessment should be made on an individual case basis because of the numerous known potential side effects of isotretinoin. Of concern, the disruption of FGFR2 signaling during embryonic development yields a teratogenicity risk in postpubertal females. 5 
D.
Topical antibiotic e Incorrect. Oral isotretinoin therapy is the best therapy for these patients. 5 E. Benzoyl peroxide e Incorrect. Although benzoyl peroxide is effective in interrupting acne pathogenesis through the degradation of lysosomal receptors and downregulation of FGFR2b, it is not sufficient in Apert syndrome. The gain-of-function FGF2 mutation in Apert syndrome requires multiple levels of pathway inhibition for successful treatment. 5 
Abbreviations used:
ANM: amelanotic nodular melanoma BCC: basal cell carcinoma FGFR2: fibroblast growth factor receptor-2 PG: pyogenic granuloma
